“ Sustainable Health Through Transformative Biomed Innovation”
Biomed Frontiers is an international conference platform that brings together researchers and professionals to explore emerging innovations, discoveries, and interdisciplinary advancements in biomedical science and healthcare.
Full Paper Submission Deadline:
01st July 2026
To be announced
Paper Acceptance Notification:
25th August 2026
Deadline for Submission of Camera-Ready Copy:
15th September 2026
Click here to download the conference proceedings.
Organized by:
School of Biomedical Sciences
Sponsored by:
Keynote Speaker
Keynote Speaker
Prof. Chamindie Punyadeera
Griffith University, Australia
Kartina Tahir Thomson is a distinguished business professional with over 25 years of expertise in actuarial science, risk management, governance, and regulatory affairs. She currently serves as a Senior Director at Willis Towers Watson (WTW), one of the world’s largest insurance consultancies, where she leads the risk, regulation, and governance proposition. In July 2024, Kartina made history as the first Malaysian to be appointed President of the Institute and Faculty of Actuaries (IFoA). In this role, she is dedicated to fostering a sustainable future for actuaries, championing collaboration and inclusivity to enhance the profession’s global influence.
As a subject matter expert in UK and European insurance regulation, Kartina advises firms on resolving their regulatory issues and adding business value by helping boards in their decision-making. She has held several senior leadership roles across the actuarial profession and financial services sector. Her previous positions include Chair of the Risk Committee at Dignity PLC, Director of Financial Services Risk & Regulation at PwC UK, General Insurance Risk Specialist and Senior Staff Member at the Bank of England, Chief Risk Officer at Navigators Underwriting Agency, and Senior Vice President at Marsh. Beyond her corporate career, she has been deeply engaged in the actuarial profession serving on the IFoA Council for seven years, as Chair of the IFoA Foundation for three years, and as a Board Director of the Actuarial Association of Europe for four years.
Keynote speaker will be reveled soon, stay tuned!
Focus areas
Focus areas will be reveled soon, stay tuned!
Genomics, proteomics, metabolomics, pharmacogenomics, biomarker discovery, personalized medicine.
AI in diagnostics, machine learning in healthcare, computational biology, big data analytics, digital health platforms.
Nanoparticles, targeted therapeutics, nano-biosensors, green nanotechnology, nanomaterials in medicine.
Stem cell therapies, tissue engineering, organoids, regenerative biomaterials, bioprinting.
Biosensors, wearable health technologies, diagnostic devices, biomedical instrumentation, assistive technologies.
Host–pathogen interactions, vaccine development, antimicrobial resistance, immunotherapy
Bench-to-bedside research, drug discovery, clinical trials, translational oncology and neuroscience.
Global health challenges, disease surveillance, environmental health, sustainable biomedical technologies.
Prof. Marc Vendrell
Marc Vendrell is Professor of Translational Chemistry and Biomedical Imaging at the College of Medicine and Veterinary Medicine in Edinburgh. His team has pioneered the design of activatable fluorophores for high-resolution optical imaging in live cells and tissues (>120 papers) and built an ambitious research programme linking physical and biomedical sciences through competitive funding (over £10M as PI, including ERC Consolidator and EIC Transition grants).
Vendrell is co-inventor of 12 patents and PI for several licenses and collaborative projects with industry (e.g., AbbVie, BioLegend, Merck, Tocris). Vendrell has a strong record of mentoring and training the next generation of translational scientists, and promotion of junior team members, with several alumni holding independent positions in academia and industry. He has won numerous awards, the latest being the Bader Prize by The Royal Society of Chemistry in 2023. Vendrell currently co-heads the IRR Chemistry Hub at the College of Medicine in Edinburgh as one of the first global hubs for collaborative non-silo’d research to catalyse innovation in medical sciences and accelerate translational outputs.
Prof. Marc Vendrell
Marc Vendrell is Professor of Translational Chemistry and Biomedical Imaging at the College of Medicine and Veterinary Medicine in Edinburgh. His team has pioneered the design of activatable fluorophores for high-resolution optical imaging in live cells and tissues (>120 papers) and built an ambitious research programme linking physical and biomedical sciences through competitive funding (over £10M as PI, including ERC Consolidator and EIC Transition grants).
Vendrell is co-inventor of 12 patents and PI for several licenses and collaborative projects with industry (e.g., AbbVie, BioLegend, Merck, Tocris). Vendrell has a strong record of mentoring and training the next generation of translational scientists, and promotion of junior team members, with several alumni holding independent positions in academia and industry. He has won numerous awards, the latest being the Bader Prize by The Royal Society of Chemistry in 2023. Vendrell currently co-heads the IRR Chemistry Hub at the College of Medicine in Edinburgh as one of the first global hubs for collaborative non-silo’d research to catalyse innovation in medical sciences and accelerate translational outputs.